×

EVIGATOR 1

What we do 1 What sets us apart 1 Our solutions 1 What we think 1
×

Global RWE 2

What we do 2 What sets us apart 2 Our solutions 2 What we think 2
×

Strategic Services 3

What we do 3 What sets us apart 3 Our solutions 3 What we think 3
0
Skip to Content
GIPAM
Why GIPAM
About
Corporate Responsibility
Careers
Services
Strategic Services
Global RWE
Evidence Synthesis
ANCHOR
ONCOCASE
EVIGATOR
Insights
News
Whitepapers & Publications
Events & Webinars
Ask me about RWE
Contact
Subscribe to Newsletter
Shop
GIPAM
Why GIPAM
About
Corporate Responsibility
Careers
Services
Strategic Services
Global RWE
Evidence Synthesis
ANCHOR
ONCOCASE
EVIGATOR
Insights
News
Whitepapers & Publications
Events & Webinars
Ask me about RWE
Contact
Subscribe to Newsletter
Shop
Folder: Why GIPAM
Back
About
Corporate Responsibility
Careers
Folder: Services
Back
Strategic Services
Global RWE
Evidence Synthesis
ANCHOR
ONCOCASE
EVIGATOR
Folder: Insights
Back
News
Whitepapers & Publications
Events & Webinars
Ask me about RWE
Contact
Subscribe to Newsletter
Shop
Shop Preliminary PICO Scoping in preparation of a JCA, using EVIGATOR
Online Shop images-12-Plan development.png Image 1 of
Online Shop images-12-Plan development.png
Online Shop images-12-Plan development.png

Preliminary PICO Scoping in preparation of a JCA, using EVIGATOR

€45,000.00

Development of a first PICO portfolio based on 3-5 proxy countries.



Included:

  • Kick-off meeting & Review of available knowledge books

  • Targeted research in each EU member state regarding publicly available guidelines & HTA decisions (3-5 proxy countries; see optionals)

  • 1-2 virtual workshops to discuss the current target product profile (TPP), the value proposition of your health technology, potential subpopulations, and available treatment options in the anticipated indication area

  • Consolidation of the above information into a PICO portfolio

  • 15-20 pages presentation (ppt) summarizing the anticipated national policy needs in relation to PICO criteria and their consolidation at EU level, also using EVIGATOR JCA module

Timeline: 6-8 weeks

Add To Cart

Development of a first PICO portfolio based on 3-5 proxy countries.



Included:

  • Kick-off meeting & Review of available knowledge books

  • Targeted research in each EU member state regarding publicly available guidelines & HTA decisions (3-5 proxy countries; see optionals)

  • 1-2 virtual workshops to discuss the current target product profile (TPP), the value proposition of your health technology, potential subpopulations, and available treatment options in the anticipated indication area

  • Consolidation of the above information into a PICO portfolio

  • 15-20 pages presentation (ppt) summarizing the anticipated national policy needs in relation to PICO criteria and their consolidation at EU level, also using EVIGATOR JCA module

Timeline: 6-8 weeks

Development of a first PICO portfolio based on 3-5 proxy countries.



Included:

  • Kick-off meeting & Review of available knowledge books

  • Targeted research in each EU member state regarding publicly available guidelines & HTA decisions (3-5 proxy countries; see optionals)

  • 1-2 virtual workshops to discuss the current target product profile (TPP), the value proposition of your health technology, potential subpopulations, and available treatment options in the anticipated indication area

  • Consolidation of the above information into a PICO portfolio

  • 15-20 pages presentation (ppt) summarizing the anticipated national policy needs in relation to PICO criteria and their consolidation at EU level, also using EVIGATOR JCA module

Timeline: 6-8 weeks

You Might Also Like

Full Review of an existing EGP
Full Review of an existing EGP
€39,000.00
Early Evidence Assessment from a regulatory/HTA/payor perspective (US, GER, UK, FR)
Early Evidence Assessment from a regulatory/HTA/payor perspective (US, GER, UK, FR)
€75,000.00
European HTA Review
European HTA Review
€29,000.00
Development and validation of a P4P model for GER
Development and validation of a P4P model for GER
€59,000.00
Full Development of an Evidence Generation Plan
Full Development of an Evidence Generation Plan
€99,000.00

Do you have questions?

CONTACT US >

Contact Us

GIPAM GmbH

Alter Holzhafen 19

23966 Wismar, Germany

Phone: +49 3841 758 1014

info@gipam-health.com

Shop Form
Please provide your contact details and we will contact you about your wishlist
Name *

Thank you for your submission.

As you’ll likely need a full contract, we’ll send you a draft within the next 48 working hours. Once received, please review the draft carefully. If you're happy to proceed, you can either sign it directly or let us know if you’d prefer to use an electronic signature process.

Should you have any feedback or request changes, we’re happy to consider them—please email Sabrina at sabrina.mueller@gipam-health.com.

Once the contract is signed, our project manager will be in touch right away to schedule your kick-off meeting.

Our Services

Strategic Services

Global RWE

Evidence Synthesis

Ask me about RWE

Learn more

News & Seminars

Whitepapers & Publications

About Us

Corporate Responsibility

Code of Conduct

Privacy Policy

Cookie Policy

Terms of Use

Connect